Your browser is no longer supported. Please, upgrade your browser.
Settings
NVAX Novavax, Inc. daily Stock Chart
NVAX [NASD]
Novavax, Inc.
Index- P/E- EPS (ttm)-0.53 Insider Own1.16% Shs Outstand382.32M Perf Week3.38%
Market Cap818.15M Forward P/E- EPS next Y-0.46 Insider Trans0.30% Shs Float378.43M Perf Month8.63%
Income-186.30M PEG- EPS next Q-0.12 Inst Own42.10% Short Float14.51% Perf Quarter44.59%
Sales38.60M P/S21.20 EPS this Y39.30% Inst Trans-3.41% Short Ratio8.19 Perf Half Y36.31%
Book/sh-0.33 P/B- EPS next Y11.50% ROA-66.80% Target Price4.20 Perf Year51.77%
Cash/sh0.33 P/C6.44 EPS next 5Y0.00% ROE179.30% 52W Range1.05 - 2.75 Perf YTD72.58%
Dividend- P/FCF- EPS past 5Y-23.70% ROI-79.50% 52W High-22.18% Beta2.35
Dividend %- Quick Ratio3.40 Sales past 5Y7.10% Gross Margin- 52W Low103.81% ATR0.13
Employees347 Current Ratio3.40 Sales Q/Q-8.30% Oper. Margin- RSI (14)61.60 Volatility7.63% 6.66%
OptionableYes Debt/Eq- EPS Q/Q22.50% Profit Margin- Rel Volume1.40 Prev Close2.05
ShortableYes LT Debt/Eq- EarningsNov 07 AMC Payout- Avg Volume6.71M Price2.14
Recom2.20 SMA2015.36% SMA5013.29% SMA20025.70% Volume9,366,198 Change4.39%
Nov-26-18Upgrade Piper Jaffray Neutral → Overweight
Sep-21-18Upgrade JP Morgan Underweight → Overweight
Mar-29-18Upgrade Seaport Global Securities Neutral → Buy $5
Mar-19-18Downgrade JP Morgan Neutral → Underweight
Mar-01-18Upgrade Citigroup Neutral → Buy
Jan-05-18Initiated B. Riley FBR, Inc. Buy $2.25
Dec-19-17Downgrade Citigroup Buy → Neutral
Oct-31-17Upgrade Citigroup Neutral → Buy
Aug-09-17Upgrade Ladenburg Thalmann Neutral → Buy
Sep-20-16Reiterated Chardan Capital Markets Neutral $5.75 → $1.50
Sep-16-16Reiterated FBR & Co. Outperform $17 → $12
Sep-16-16Downgrade Wedbush Outperform → Neutral $14 → $2
Sep-16-16Downgrade Piper Jaffray Overweight → Neutral
Sep-16-16Downgrade Ladenburg Thalmann Buy → Neutral
Sep-16-16Downgrade JP Morgan Overweight → Neutral
Sep-16-16Downgrade Citigroup Buy → Neutral
Apr-04-16Initiated Chardan Capital Markets Neutral $5.75
Jul-09-15Reiterated Citigroup Buy $10 → $18
Jun-09-15Initiated Guggenheim Buy
Mar-11-14Reiterated Ladenburg Thalmann Buy $4 → $10
Dec-08-18 03:45PM  Here's What Pushed Novavax Stock Up 17.6% in November Motley Fool
Dec-04-18 04:05PM  Novavax Announces Leadership Promotions GlobeNewswire -7.31%
09:00AM  Some of December's Most Interesting Stocks ACCESSWIRE
Dec-03-18 02:00PM  2 Biotech Stocks Poised for Big Gains in 2019 Motley Fool +5.80%
08:10AM  Analysis: Positioning to Benefit within Symantec, ACADIA Pharmaceuticals, Novavax, BBX Capital, Paychex, and US Foods Holding Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
Dec-02-18 11:33AM  Why Novavax Is Up 60% in 2018 Motley Fool
Nov-28-18 04:37PM  Why Novavax Soared Today Motley Fool +11.17%
Nov-27-18 06:55AM  Today's Research Reports on Trending Tickers: Novavax and ACADIA Pharmaceuticals ACCESSWIRE
Nov-26-18 12:55PM  4 Healthcare Stocks Seeing New Highs On Monday ACCESSWIRE +7.56%
Nov-17-18 05:33PM  Edited Transcript of NVAX earnings conference call or presentation 7-Nov-18 9:30pm GMT Thomson Reuters StreetEvents
Nov-12-18 04:05PM  Novavax Expands Leadership with Several Key Management Promotions GlobeNewswire
01:44PM  Does Novavax Incs (NASDAQ:NVAX) CEO Pay Reflect Performance? Simply Wall St.
Nov-08-18 02:20PM  What Novavax needs for success as it advances blockbuster vaccine candidates American City Business Journals -6.60%
Nov-07-18 08:00PM  Novavax (NVAX) Reports Q3 Loss, Lags Revenue Estimates Zacks
06:55PM  Novavax: 3Q Earnings Snapshot Associated Press
04:05PM  Novavax Reports Third Quarter 2018 Financial Results GlobeNewswire
07:20AM  Q3 Earnings Outlook For Novavax Benzinga
Nov-02-18 06:50PM  Novavax (NVAX) Gains As Market Dips: What You Should Know Zacks
Nov-01-18 04:15PM  Novavax to Host Conference Call to Discuss Third Quarter Financial Results on November 7, 2018 GlobeNewswire +7.95%
04:05PM  Novavax Appoints Rachel King to Board of Directors GlobeNewswire
Oct-31-18 10:51AM  What's in the Cards for Novavax (NVAX) This Earnings Season? Zacks
Oct-24-18 08:25AM  Consolidated Research: 2018 Summary Expectations for Novavax, Caesars Entertainment, SeaWorld Entertainment, LendingTree, CVS Health, and TherapeuticsMD Fundamental Analysis, Key Performance Indications GlobeNewswire -8.15%
Oct-15-18 08:00AM  Novavax Shares Gain as its Lead Compounds Move Forward, Analysts Review and Target ACCESSWIRE
Oct-14-18 06:32AM  3 Top Small-Cap Stocks to Buy in October Motley Fool
Oct-10-18 06:44PM  Top 3 Healthcare Penny Stocks for 2018 Investopedia -6.34%
01:59PM  Here's Why Novavax Gained 20.5% in September Motley Fool
10:30AM  Major Biotech Announcements Moving the Market ACCESSWIRE
Oct-09-18 06:00AM  3 Top Small-Cap Stocks to Buy in October Motley Fool
Oct-08-18 10:26AM  FBR: Novavax Looks Healthy Ahead Of Catalysts Benzinga
Oct-04-18 08:55AM  Do Options Traders Know Something About Novavax (NVAX) Stock We Don't? Zacks
08:00AM  Today's Research Reports on Trending Tickers: Amarin and Novavax ACCESSWIRE
Oct-02-18 04:05PM  Novavax to Highlight RSV Program Data at Two Upcoming Meetings GlobeNewswire
Sep-30-18 07:01AM  Better Buy: Novavax, Inc. vs. Pfizer Inc. Motley Fool
Sep-26-18 04:05PM  Novavax to Present at Two Upcoming Investor Conferences GlobeNewswire -7.54%
08:59AM  Novavax (NVAX) Catches Eye: Stock Jumps 7.6% Zacks
Sep-25-18 07:00AM  Novavax Initiates Phase 2 Clinical Trial of NanoFlu in Older Adults GlobeNewswire +7.57%
Sep-24-18 03:43PM  Why Novavax Inc. Is Surging 14.4% Higher Today Motley Fool +15.63%
Sep-21-18 04:30PM  Why Transocean, Novavax, and Steelcase Jumped Today Motley Fool +8.84%
10:03AM  ResVax, NanoFlu Prospects Earn Novavax A Double Upgrade Benzinga
09:09AM  Novavax's stock soars after J.P. Morgan swings to bullish from bearish ahead of trial results MarketWatch
Sep-12-18 06:02AM  3 Stocks That Could Double Your Money Motley Fool
Sep-10-18 04:17PM  Here's Why Novavax, Inc. Jumped 22.8% in August Motley Fool
09:00AM  Where Will Novavax, Inc. Be in 1 Year? Motley Fool
Sep-05-18 06:00AM  3 Top Stocks Under $10 Motley Fool
Sep-04-18 04:46PM  Wall Street Has Given Up on These 3 Stocks, and That's a Huge Mistake Motley Fool
Aug-31-18 07:45AM  Research Report Identifies FS Investment, Rush Enterprises, GlycoMimetics, Federal Signal, ATN International, and Novavax with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Aug-28-18 04:05PM  Novavax to Participate at Two Upcoming Investor Conferences GlobeNewswire
Aug-27-18 08:56AM  Is the Options Market Predicting a Spike in Novavax (NVAX) Stock? Zacks
Aug-23-18 01:45AM  Edited Transcript of NVAX earnings conference call or presentation 8-Aug-18 8:30pm GMT Thomson Reuters StreetEvents
Aug-15-18 06:02AM  5 Promising Vaccines in Development -- and the Stocks Poised to Profit From Them Motley Fool -6.62%
Aug-09-18 12:07PM  Why Novavax, Inc. Shares Are Soaring Today Motley Fool +21.49%
08:00AM  Today's Research Reports on Trending Tickers: Novavax and INSYS Therapeutics ACCESSWIRE
Aug-08-18 08:30PM  Novavax (NVAX) Reports Q2 Loss, Tops Revenue Estimates Zacks
07:22PM  Novavax: 2Q Earnings Snapshot Associated Press
04:05PM  Novavax Reports Second Quarter 2018 Financial Results GlobeNewswire
02:30PM  Novavax, Inc. to Host Earnings Call ACCESSWIRE
Aug-01-18 04:05PM  Novavax to Host Conference Call to Discuss Second Quarter Financial Results on August 8, 2018 GlobeNewswire
Jul-28-18 08:00AM  How to Invest in Clinical-Stage Biotechs Without Losing Money Motley Fool
Jul-26-18 07:55AM  Consolidated Research: 2018 Summary Expectations for At Home Group, Royal Bank Of Canada, Curis, Novavax, HNI, and Freshpet Fundamental Analysis, Key Performance Indications GlobeNewswire -6.20%
Jul-19-18 07:29AM  Better Buy: Novavax, Inc. vs. Pfizer Motley Fool
Jul-12-18 09:25AM  Why Novavax Stock Buckled in June Motley Fool
Jul-05-18 07:25AM  Free Technical Reports on Novavax and Three Additional Biotech Equities ACCESSWIRE
Jun-25-18 08:10AM  Today's Research Reports on Trending Tickers: Novavax and Nektar Therapeutics ACCESSWIRE
Jun-24-18 07:17AM  3 Stocks That Could Make You Rich Motley Fool
Jun-16-18 07:33AM  Are These 2 Dark Horse Vaccine Makers Worth the Risk? Motley Fool
Jun-13-18 05:11PM  New England Journal of Medicine Publishes Novavax' NanoFlu Clinical Trial Data GlobeNewswire
02:13PM  3 Penny Stocks Poised for Growth the Rest of 2018 InvestorPlace
May-22-18 07:00AM  Free Technical Insights on OPKO Health and Three Other Biotech Stocks ACCESSWIRE
May-17-18 06:33AM  3 Top Stocks Under $5 Motley Fool
May-16-18 11:52AM  Edited Transcript of NVAX earnings conference call or presentation 9-May-18 8:30pm GMT Thomson Reuters StreetEvents +7.19%
May-09-18 07:06PM  Novavax: 1Q Earnings Snapshot Associated Press +5.56%
04:06PM  Novavax Reports First Quarter 2018 Financial Results GlobeNewswire
May-07-18 07:02AM  Novavax Reaches Significant Enrollment Milestone in the Prepare(TM) Phase 3 Trial of its RSV F Vaccine GlobeNewswire
May-06-18 07:07AM  Will Novavax Incs (NASDAQ:NVAX) Earnings Grow In The Years Ahead? Simply Wall St.
May-03-18 01:00AM  Novavax to Host Conference Call to Discuss First Quarter Financial Results on May 9, 2018 GlobeNewswire
May-02-18 04:05PM  Novavax to Host Conference Call to Discuss First Quarter Financial Results on May 9, 2018 GlobeNewswire
Apr-30-18 09:30AM  3 Stocks That Could Put Amazon's Returns to Shame Motley Fool
Apr-26-18 10:25AM  Has Novavax (NVAX) Outpaced Other Medical Stocks This Year? Zacks
Apr-23-18 02:00PM  Don't Get Greedy With Novavax, Inc. Stock Motley Fool
Apr-19-18 09:35AM  3 Biotech Stocks That Will Thrive Amid Market Instability InvestorPlace
Apr-17-18 06:33AM  Buy Novavax After Its Latest Pullback? Motley Fool
Apr-16-18 04:06PM  Novavax Announces Closing of Public Offering GlobeNewswire
Apr-13-18 08:20AM  Todays Research Reports on Stocks to Watch: Novavax and Pfizer ACCESSWIRE
Apr-12-18 11:07AM  Here's Why Novavax, Inc. Is Sinking Motley Fool -12.98%
09:07AM  Novavax's stock plunges on heavy volume after public offering prices at deep discount MarketWatch
Apr-11-18 09:02PM  Novavax Prices Public Offering of Common Stock GlobeNewswire
08:50PM  Novavax Prices Public Offering of Common Stock GlobeNewswire
08:13PM  Novavax announces plans for public offering American City Business Journals
04:01PM  Novavax Announces Proposed Public Offering of Common Stock GlobeNewswire
Apr-06-18 09:28AM  Pick 3 Biotech Money-Spinning Bets Amid Market Instability Zacks
Apr-03-18 06:33AM  3 Top Small-Cap Biotech Stocks for Aggressive Investors Motley Fool
Apr-02-18 09:01AM  Novavax to Present Clinical Data on RSV F and NanoFlu(TM) Vaccines at World Vaccine Congress GlobeNewswire
09:00AM  Novavax to Present Clinical Data on RSV F and NanoFlu Vaccines at World Vaccine Congress GlobeNewswire
Mar-28-18 06:01AM  Forget Merck: Novavax, Inc. Is a Better Vaccine Stock Motley Fool
Mar-23-18 09:38AM  When Will Novavax Inc (NASDAQ:NVAX) Become Profitable? Simply Wall St.
Mar-19-18 12:45PM  Eeny, Meeny, Miny, Moe: JPMorgan Downgrades 4 Biotechs In Portfolio Rebalancing Benzinga
Mar-16-18 06:30AM  Why Novavax's CEO called last quarter 'the most significant' in corporate history American City Business Journals
Mar-15-18 11:20PM  Edited Transcript of NVAX earnings conference call or presentation 14-Mar-18 9:00pm GMT Thomson Reuters StreetEvents
08:20AM  Todays Research Reports on Trending Tickers: Novavax and RXi Pharmaceuticals ACCESSWIRE
Mar-14-18 06:00PM  Novavax reports 4Q loss Associated Press
Novavax, Inc., together with its subsidiary, Novavax AB, a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of recombinant nanoparticle vaccines and adjuvants. Its lead adjuvant is Matrix-M that is used to enable a vaccine to enhance the amplitude of the immune response and qualitatively change it, enhance its specificity to provide protection against related microorganisms, as well as allows immunization with much lower doses of antigen. The company develops respiratory syncytial (RSV) virus fusion protein nanoparticle vaccine candidate for infants via maternal immunization in Phase III clinical trial; older adults in Phase II clinical trial; and children six months to five years of age in Phase I clinical trial. Novavax, Inc. also develops NanoFlu vaccine, which is in Phase I/II clinical trial for treating seasonal influenza in older adults; and Ebola virus glycoprotein vaccine that is in Phase I clinical trial. Its preclinical programs include Zika virus; combination respiratory vaccine candidate to protect against RSV and seasonal influenza, as well as other infectious disease vaccine candidates. Novavax, Inc. was founded in 1987 and is headquartered in Gaithersburg, Maryland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Glenn Gregory MPresident, R&DJul 31Buy0.8813,00711,44660,218Aug 01 05:11 PM
Glenn Gregory MPresident, R&DMay 14Buy1.6420,00032,80047,211May 15 11:17 AM
Trizzino JohnSVP, CBO and CFOMay 14Buy1.6450,00081,995138,965May 15 11:16 AM
Erck Stanley CPresident and CEOMay 14Buy1.65100,000164,620328,279May 15 11:13 AM
Glenn Gregory MPresident, R&DJan 31Buy0.8812,78411,25027,211Feb 01 04:15 PM